Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J J Godfroid

Showing results (21-30 of 47) with videos related to

Pageof 5
Sort By:
Agents and Actions|December 1, 1982
Radio-labelling of 1-O-alkyl, 2-O-acetyl, sn-glycero-3-phosphorylcholine, 1-O-(9,10-di3H)-octadecyl PAF-acetherJ L Morgat, J Roy, B Wichrowski, et al.
Journal of Lipid Mediators and Cell Signalling|January 1, 1997
Design and modeling of new platelet-activating factor antagonists. 2. Synthesis and biological activity of 1,4-bis-(3',4',5'-trimethoxybenzoyl)-2-alkyl and 2-alkyloxymethylpiperazinesF Tavet, A Lamouri, F Heymans, et al.
Journal of Medicinal Chemistry|February 1, 1988
Structure-activity relationship in PAF-acether. 4. Synthesis and biological activities of carboxylate isosteresB Wichrowski, S Jouquey, C Broquet, et al.
Journal of Lipid Mediators|May 1, 1991
Structure-activity relationships in platelet-activating factor (PAF). 5. Synthesis and in vitro antagonistic activities of ketophosphonatesA Furno-de Winter, C Broquet, J P Haelters, et al.
Journal of Lipid Mediators and Cell Signalling|May 1, 1996
Structure-activity relationships in platelet-activating factor (PAF). 8. Tetrahydrofuran derivatives as dual PAF antagonists and acetylcholinesterase inhibitors: anti-acetylcholinesterase activity and comparative SARL Le Texier, E Favre, N Ronzani, et al.
Journal of Lipid Mediators|July 1, 1989
PAF-receptor. 1. 'Cache-oreilles' effect of selected high-potency platelet-activating factor (PAF) antagonistsG Dive, J J Godfroid, J Lamotte-Brasseur, et al.
British Journal of Pharmacology|January 10, 1998
Stimulation of insulin release from the MIN6 cell line by a new imidazoline compound, S-21663: evidence for the existence of a novel imidazoline site in beta cellsL Le Brigand, A Virsolvy, K Peyrollier, et al.
Journal of Medicinal Chemistry|April 16, 1993
Design and modeling of new platelet-activating factor antagonists. 1. Synthesis and biological activity of 1,4-bis(3',4',5'-trimethoxybenzoyl)-2-[[(substituted carbonyl and carbamoyl)oxy]methyl]piperazinesA Lamouri, F Heymans, F Tavet, et al.
Journal of Lipid Mediators and Cell Signalling|May 1, 1996
Structure-activity relationships in platelet-activating factor (PAF). 7. Tetrahydrofuran derivatives as dual PAF antagonists and acetylcholinesterase inhibitors. Synthesis and PAF-antagonistic activityL Le Texier, E Favre, C Redeuilh, et al.
Journal of Lipid Mediators|February 1, 1992
Structure-activity relationships in platelet-activating factor (PAF antagonists). 6. Synthesis and in vitro antagonistic activities of 2-substituted 5-oxotetrahydrofuransE Favre, F Heymans, C Redeuilh, et al.
Pageof 5

Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
Agents and Actions|December 1, 1982
Radio-labelling of 1-O-alkyl, 2-O-acetyl, sn-glycero-3-phosphorylcholine, 1-O-(9,10-di3H)-octadecyl PAF-acetherJ L Morgat, J Roy, B Wichrowski, et al.
Journal of Lipid Mediators and Cell Signalling|January 1, 1997
Design and modeling of new platelet-activating factor antagonists. 2. Synthesis and biological activity of 1,4-bis-(3',4',5'-trimethoxybenzoyl)-2-alkyl and 2-alkyloxymethylpiperazinesF Tavet, A Lamouri, F Heymans, et al.
Journal of Medicinal Chemistry|February 1, 1988
Structure-activity relationship in PAF-acether. 4. Synthesis and biological activities of carboxylate isosteresB Wichrowski, S Jouquey, C Broquet, et al.
Journal of Lipid Mediators|May 1, 1991
Structure-activity relationships in platelet-activating factor (PAF). 5. Synthesis and in vitro antagonistic activities of ketophosphonatesA Furno-de Winter, C Broquet, J P Haelters, et al.
Journal of Lipid Mediators and Cell Signalling|May 1, 1996
Structure-activity relationships in platelet-activating factor (PAF). 8. Tetrahydrofuran derivatives as dual PAF antagonists and acetylcholinesterase inhibitors: anti-acetylcholinesterase activity and comparative SARL Le Texier, E Favre, N Ronzani, et al.
Journal of Lipid Mediators|July 1, 1989
PAF-receptor. 1. 'Cache-oreilles' effect of selected high-potency platelet-activating factor (PAF) antagonistsG Dive, J J Godfroid, J Lamotte-Brasseur, et al.
British Journal of Pharmacology|January 10, 1998
Stimulation of insulin release from the MIN6 cell line by a new imidazoline compound, S-21663: evidence for the existence of a novel imidazoline site in beta cellsL Le Brigand, A Virsolvy, K Peyrollier, et al.
Journal of Medicinal Chemistry|April 16, 1993
Design and modeling of new platelet-activating factor antagonists. 1. Synthesis and biological activity of 1,4-bis(3',4',5'-trimethoxybenzoyl)-2-[[(substituted carbonyl and carbamoyl)oxy]methyl]piperazinesA Lamouri, F Heymans, F Tavet, et al.
Journal of Lipid Mediators and Cell Signalling|May 1, 1996
Structure-activity relationships in platelet-activating factor (PAF). 7. Tetrahydrofuran derivatives as dual PAF antagonists and acetylcholinesterase inhibitors. Synthesis and PAF-antagonistic activityL Le Texier, E Favre, C Redeuilh, et al.
Journal of Lipid Mediators|February 1, 1992
Structure-activity relationships in platelet-activating factor (PAF antagonists). 6. Synthesis and in vitro antagonistic activities of 2-substituted 5-oxotetrahydrofuransE Favre, F Heymans, C Redeuilh, et al.
Pageof 5